These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23866670)
1. [Advances on effects of triptolide with non-small cell lung cancer]. Wang L; Song Y Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):378-81. PubMed ID: 23866670 [TBL] [Abstract][Full Text] [Related]
2. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer. Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883 [TBL] [Abstract][Full Text] [Related]
3. Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells. Ren T; Tang YJ; Wang MF; Wang HS; Liu Y; Qian X; Chang C; Chen MW Oncol Rep; 2020 Nov; 44(5):2288-2296. PubMed ID: 33000264 [TBL] [Abstract][Full Text] [Related]
4. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking. Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560 [TBL] [Abstract][Full Text] [Related]
5. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer. Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910 [TBL] [Abstract][Full Text] [Related]
6. The Roles of Plant-Derived Triptolide on Non-Small Cell Lung Cancer. Wei J; Yan Y; Chen X; Qian L; Zeng S; Li Z; Dai S; Gong Z; Xu Z Oncol Res; 2019 Jul; 27(7):849-858. PubMed ID: 30982492 [TBL] [Abstract][Full Text] [Related]
7. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha. Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132 [TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3. Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924 [TBL] [Abstract][Full Text] [Related]
9. Triptolide and Its Derivatives as Cancer Therapies. Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442 [TBL] [Abstract][Full Text] [Related]
10. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes. Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258 [TBL] [Abstract][Full Text] [Related]
11. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis. Reno TA; Kim JY; Raz DJ Ann Thorac Surg; 2015 Nov; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168 [TBL] [Abstract][Full Text] [Related]
12. Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells. Zheng L; Jia J; Dai H; Wan L; Liu J; Hu L; Zhou M; Qiu M; Chen X; Chang L; Kim JY; Reckamp K; Raz DJ; Xia Z; Shen B Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533220 [TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway. He S; Chen M; Lin X; Lv Z; Liang R; Huang L Eur J Pharmacol; 2020 Jan; 867():172811. PubMed ID: 31756335 [TBL] [Abstract][Full Text] [Related]
14. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer. Kumar A; Corey C; Scott I; Shiva S; D'Cunha J PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149 [TBL] [Abstract][Full Text] [Related]
15. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway. Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691 [TBL] [Abstract][Full Text] [Related]
16. Triptolide reduces proliferation and enhances apoptosis of human non-small cell lung cancer cells through PTEN by targeting miR-21. Li X; Zang A; Jia Y; Zhang J; Fan W; Feng J; Duan M; Zhang L; Huo R; Jiao J; Zhu X Mol Med Rep; 2016 Mar; 13(3):2763-8. PubMed ID: 26847601 [TBL] [Abstract][Full Text] [Related]
17. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling. Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475 [TBL] [Abstract][Full Text] [Related]
18. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180. Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791 [TBL] [Abstract][Full Text] [Related]
19. Triptolide Suppressed the Microglia Activation to Improve Spinal Cord Injury Through miR-96/IKKβ/NF-κB Pathway. Huang Y; Zhu N; Chen T; Chen W; Kong J; Zheng W; Ruan J Spine (Phila Pa 1976); 2019 Jun; 44(12):E707-E714. PubMed ID: 31150368 [TBL] [Abstract][Full Text] [Related]
20. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway. Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]